Effects of topiramate on weight and metabolism in children with epilepsy
Article first published online: 8 JUN 2009
DOI: 10.1111/j.1651-2227.2009.01349.x
© 2009 The Author(s)/Journal Compilation © 2009 Foundation Acta Pædiatrica
Additional Information
How to Cite
Li, H.-f., Zou, Y., Xia, Z.-z., Gao, F., Feng, J.-h. and Yang, C.-w. (2009), Effects of topiramate on weight and metabolism in children with epilepsy. Acta Paediatrica, 98: 1521–1525. doi: 10.1111/j.1651-2227.2009.01349.x
Publication History
- Issue published online: 27 JUL 2009
- Article first published online: 8 JUN 2009
- Received 26 December 2008; revised 31 March 2009; accepted 17 April 2009.
- Abstract
- Article
- References
- Cited By
Keywords:
- Adiponectin;
- Children;
- Epilepsy;
- Topiramate
Abstract
Aim: To explore the mechanism of topiramate-induced weight loss in epilepsy children by monitoring metabolism indices.
Methods: Children with epilepsy were treated with topiramate at their first clinical visit. Metabolism indices including body mass index (BMI) and its SD scores, leptin, adiponectin, leptin/adiponectin (L/A), lipid profile-insulin and Homeostasis Model Assessments (HOMA) index were collected before and after treatment.
Results: Topiramate treatment significantly reduced L/A (t = 2.156, p = 0.031), and markedly increased the serum level of adiponectin (t = 3.124, p = 0.002). Moreover, there were no relationships between the metabolism indices and dosages of topiramate (p > 0.05).
Conclusion: Our studies find that topiramate treatment in epilepsy children increases energy metabolism, resulting in weight loss. It has been demonstrated that adiponectin play a significant role in metabolic regulations.

1651-2227/asset/olbannercenter.gif?v=1&s=aed7f4736e780f26e96740fe0c8faf09ec8d2946)
